Deletion of protease-activated receptor 2 prolongs survival of scrapie-inoculated mice

References

1. Adams M. N., Ramachandran R., Yau M. K., Suen J. Y., Fairlie D. P., Hollenberg M. D., Hooper J. D. 2011; Structure, function and pathophysiology of protease activated receptors. Pharmacol Ther 130:248–282 [View Article][PubMed]
   [Google Scholar]
2. Afkhami-Goli A., Noorbakhsh F., Keller A. J., Vergnolle N., Westaway D., Jhamandas J. H., Andrade-Gordon P., Hollenberg M. D., Arab H. other authors 2007; Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer’s disease. J Immunol 179:5493–5503[PubMed] [CrossRef]
   [Google Scholar]
3. Bushell T. 2007; The emergence of proteinase-activated receptor-2 as a novel target for the treatment of inflammation-related CNS disorders. J Physiol 581:7–16 [View Article][PubMed]
   [Google Scholar]
4. Hansen K. K., Oikonomopoulou K., Baruch A., Ramachandran R., Beck P., Diamandis E. P., Hollenberg M. D. 2008; Proteinases as hormones: targets and mechanisms for proteolytic signaling. Biol Chem 389:971–982 [View Article][PubMed]
   [Google Scholar]
5. Hwang D., Lee I. Y., Yoo H., Gehlenborg N., Cho J. H., Petritis B., Baxter D., Pitstick R., Young R. et al. 2009; A systems approach to prion disease. Mol Syst Biol 5:252 [View Article][PubMed]
   [Google Scholar]
6. Julak J., Janouskova O., Scholtz V., Holada K. 2011; Inactivation of prions using electrical DC discharges at atmospheric pressure and ambient temperature. Plasma Process Polym 8:316–323 [View Article]
   [Google Scholar]
7. Luo W., Wang Y., Reiser G. 2007; Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection. Brain Res Brain Res Rev 56:331–345 [View Article][PubMed]
   [Google Scholar]
8. Mahal S. P., Demczyk C. A., Smith E. W. Jr, Klohn P. C., Weissmann C. 2008; Assaying prions in cell culture: the standard scrapie cell assay (SSCA) and the scrapie cell assay in end point format (SCEPA). Methods Mol Biol 459:49–68 [View Article][PubMed]
   [Google Scholar]
9. Noorbakhsh F., Tsutsui S., Vergnolle N., Boven L. A., Shariat N., Vodjgani M., Warren K. G., Andrade-Gordon P., Hollenberg M. D., Power C. 2006; Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med 203:425–435 [View Article][PubMed]
   [Google Scholar]
10. Olejár T., Matěj R., Zadinová M., Poucková P. 2002; Proteinase-activated receptor-2 expression on cerebral neurones after radiation damage: immunohistochemical observation in Wistar rats. Int J Tissue React 24:81–88[PubMed]
    [Google Scholar]
11. Ossovskaya V. S., Bunnett N. W. 2004; Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84:579–621 [View Article][PubMed]
    [Google Scholar]
12. Panigaj M., Glier H., Wildova M., Holada K. 2011; Expression of prion protein in mouse erythroid progenitors and differentiating murine erythroleukemia cells. PLoS ONE 6:e24599 [View Article][PubMed]
    [Google Scholar]
13. Schmidlin F., Amadesi S., Dabbagh K., Lewis D. E., Knott P., Bunnett N. W., Gater P. R., Geppetti P., Bertrand C., Stevens M. E. 2002; Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J Immunol 169:5315–5321 [CrossRef]
    [Google Scholar]
14. Severino B., Santagada V., Perissutti E., Fiorino F., Frecentese F., De Angelis F., Esposito A., Caliendo G. 2009; Recent advances in synthesis of PAR ligands as therapeutic strategy for inflammatory diseases. Mini Rev Med Chem 9:653–663 [View Article][PubMed]
    [Google Scholar]
15. Sevigny L. M., Zhang P., Bohm A., Lazarides K., Perides G., Covic L., Kuliopulos A. 2011; Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins. Proc Natl Acad Sci U S A 108:8491–8496 [View Article][PubMed]
    [Google Scholar]
16. Smith-Swintosky V. L., Cheo-Isaacs C. T., D’Andrea M. R., Santulli R. J., Darrow A. L., Andrade-Gordon P. 1997; Protease-activated receptor-2 (PAR-2) is present in the rat hippocampus and is associated with neurodegeneration. J Neurochem 69:1890–1896 [View Article][PubMed]
    [Google Scholar]
17. Soh U. J., Dores M. R., Chen B., Trejo J. 2010; Signal transduction by protease-activated receptors. Br J Pharmacol 160:191–203 [View Article][PubMed]
    [Google Scholar]
18. Soto C., Satani N. 2011; The intricate mechanisms of neurodegeneration in prion diseases. Trends Mol Med 17:14–24 [View Article][PubMed]
    [Google Scholar]
19. Tamgüney G., Giles K., Glidden D. V., Lessard P., Wille H., Tremblay P., Groth D. F., Yehiely F., Korth C. et al. 2008; Genes contributing to prion pathogenesis. J Gen Virol 89:1777–1788 [View Article][PubMed]
    [Google Scholar]
20. Wang Y., Luo W., Reiser G. 2008; Trypsin and trypsin-like proteases in the brain: proteolysis and cellular functions. Cell Mol Life Sci 65:237–252 [View Article][PubMed]
    [Google Scholar]